Logo image of IMAX

IMAX CORP (IMAX) Stock Fundamental Analysis

NYSE:IMAX - New York Stock Exchange, Inc. - CA45245E1097 - Common Stock - Currency: USD

26.03  -0.9 (-3.34%)

After market: 26.16 +0.13 (+0.5%)

Fundamental Rating

5

IMAX gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 71 industry peers in the Entertainment industry. IMAX has only an average score on both its financial health and profitability. IMAX is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year IMAX was profitable.
IMAX had a positive operating cash flow in the past year.
In the past 5 years IMAX reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: IMAX reported negative operating cash flow in multiple years.
IMAX Yearly Net Income VS EBIT VS OCF VS FCFIMAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M 100M -100M

1.2 Ratios

With a decent Return On Assets value of 2.75%, IMAX is doing good in the industry, outperforming 75.76% of the companies in the same industry.
Looking at the Return On Equity, with a value of 8.05%, IMAX is in the better half of the industry, outperforming 78.79% of the companies in the same industry.
IMAX's Return On Invested Capital of 3.91% is fine compared to the rest of the industry. IMAX outperforms 71.21% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for IMAX is significantly below the industry average of 91.11%.
The last Return On Invested Capital (3.91%) for IMAX is above the 3 year average (2.38%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.75%
ROE 8.05%
ROIC 3.91%
ROA(3y)-0.73%
ROA(5y)-2.27%
ROE(3y)-1.88%
ROE(5y)-6.88%
ROIC(3y)2.38%
ROIC(5y)N/A
IMAX Yearly ROA, ROE, ROICIMAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10 -20 -30

1.3 Margins

IMAX has a better Profit Margin (6.74%) than 80.30% of its industry peers.
In the last couple of years the Profit Margin of IMAX has grown nicely.
IMAX's Operating Margin of 11.21% is fine compared to the rest of the industry. IMAX outperforms 78.79% of its industry peers.
In the last couple of years the Operating Margin of IMAX has declined.
IMAX's Gross Margin of 53.69% is fine compared to the rest of the industry. IMAX outperforms 60.61% of its industry peers.
IMAX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 11.21%
PM (TTM) 6.74%
GM 53.69%
OM growth 3YN/A
OM growth 5Y-3.91%
PM growth 3YN/A
PM growth 5Y2.11%
GM growth 3Y53.88%
GM growth 5Y0.59%
IMAX Yearly Profit, Operating, Gross MarginsIMAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100

5

2. Health

2.1 Basic Checks

IMAX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
IMAX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IMAX Yearly Shares OutstandingIMAX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
IMAX Yearly Total Debt VS Total AssetsIMAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

IMAX has an Altman-Z score of 1.82. This is not the best score and indicates that IMAX is in the grey zone with still only limited risk for bankruptcy at the moment.
IMAX's Altman-Z score of 1.82 is fine compared to the rest of the industry. IMAX outperforms 60.61% of its industry peers.
The Debt to FCF ratio of IMAX is 5.77, which is a neutral value as it means it would take IMAX, 5.77 years of fcf income to pay off all of its debts.
IMAX has a better Debt to FCF ratio (5.77) than 68.18% of its industry peers.
IMAX has a Debt/Equity ratio of 0.95. This is a neutral value indicating IMAX is somewhat dependend on debt financing.
The Debt to Equity ratio of IMAX (0.95) is worse than 60.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF 5.77
Altman-Z 1.82
ROIC/WACC0.58
WACC6.74%
IMAX Yearly LT Debt VS Equity VS FCFIMAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.96 indicates that IMAX should not have too much problems paying its short term obligations.
The Current ratio of IMAX (1.96) is better than 75.76% of its industry peers.
A Quick Ratio of 1.69 indicates that IMAX should not have too much problems paying its short term obligations.
IMAX has a Quick ratio of 1.69. This is in the better half of the industry: IMAX outperforms 74.24% of its industry peers.
Industry RankSector Rank
Current Ratio 1.96
Quick Ratio 1.69
IMAX Yearly Current Assets VS Current LiabilitesIMAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

3

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 1.06% over the past year.
IMAX shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.17% yearly.
EPS 1Y (TTM)1.06%
EPS 3YN/A
EPS 5Y-2.17%
EPS Q2Q%58.82%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%7.73%

3.2 Future

The Earnings Per Share is expected to grow by 27.68% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 5.73% on average over the next years.
EPS Next Y30.52%
EPS Next 2Y23.81%
EPS Next 3Y32.98%
EPS Next 5Y27.68%
Revenue Next Year14.07%
Revenue Next 2Y9.93%
Revenue Next 3Y5.73%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
IMAX Yearly Revenue VS EstimatesIMAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M
IMAX Yearly EPS VS EstimatesIMAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 27.40, which means the current valuation is very expensive for IMAX.
IMAX's Price/Earnings ratio is a bit cheaper when compared to the industry. IMAX is cheaper than 72.73% of the companies in the same industry.
IMAX is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 29.63, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 20.99, the valuation of IMAX can be described as rather expensive.
Based on the Price/Forward Earnings ratio, IMAX is valued a bit cheaper than 78.79% of the companies in the same industry.
IMAX's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.68.
Industry RankSector Rank
PE 27.4
Fwd PE 20.99
IMAX Price Earnings VS Forward Price EarningsIMAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, IMAX is valued a bit cheaper than 68.18% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, IMAX is valued a bit cheaper than 74.24% of the companies in the same industry.
Industry RankSector Rank
P/FCF 28.62
EV/EBITDA 16.08
IMAX Per share dataIMAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

IMAX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IMAX has a very decent profitability rating, which may justify a higher PE ratio.
IMAX's earnings are expected to grow with 32.98% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.9
PEG (5Y)N/A
EPS Next 2Y23.81%
EPS Next 3Y32.98%

0

5. Dividend

5.1 Amount

No dividends for IMAX!.
Industry RankSector Rank
Dividend Yield N/A

IMAX CORP

NYSE:IMAX (2/21/2025, 8:04:00 PM)

After market: 26.16 +0.13 (+0.5%)

26.03

-0.9 (-3.34%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)02-19 2025-02-19/amc
Earnings (Next)04-23 2025-04-23
Inst Owners90.81%
Inst Owner Change3.97%
Ins Owners19.43%
Ins Owner Change-0.07%
Market Cap1.37B
Analysts80
Price Target28.97 (11.29%)
Short Float %10.63%
Short Ratio7.57
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)95.49%
Min EPS beat(2)52.13%
Max EPS beat(2)138.86%
EPS beat(4)4
Avg EPS beat(4)119.65%
Min EPS beat(4)51.79%
Max EPS beat(4)235.82%
EPS beat(8)7
Avg EPS beat(8)75.39%
EPS beat(12)8
Avg EPS beat(12)16.54%
EPS beat(16)11
Avg EPS beat(16)18.53%
Revenue beat(2)1
Avg Revenue beat(2)5.21%
Min Revenue beat(2)-4.32%
Max Revenue beat(2)14.74%
Revenue beat(4)1
Avg Revenue beat(4)1.96%
Min Revenue beat(4)-4.32%
Max Revenue beat(4)14.74%
Revenue beat(8)5
Avg Revenue beat(8)3.58%
Revenue beat(12)6
Avg Revenue beat(12)3.84%
Revenue beat(16)8
Avg Revenue beat(16)4.74%
PT rev (1m)1.67%
PT rev (3m)9.71%
EPS NQ rev (1m)-29.38%
EPS NQ rev (3m)-29.38%
EPS NY rev (1m)-7.49%
EPS NY rev (3m)-8.25%
Revenue NQ rev (1m)-12.53%
Revenue NQ rev (3m)-12.53%
Revenue NY rev (1m)-3.22%
Revenue NY rev (3m)-3.44%
Valuation
Industry RankSector Rank
PE 27.4
Fwd PE 20.99
P/S 3.97
P/FCF 28.62
P/OCF 21.64
P/B 4.74
P/tB 7.1
EV/EBITDA 16.08
EPS(TTM)0.95
EY3.65%
EPS(NY)1.24
Fwd EY4.76%
FCF(TTM)0.91
FCFY3.49%
OCF(TTM)1.2
OCFY4.62%
SpS6.56
BVpS5.49
TBVpS3.67
PEG (NY)0.9
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.75%
ROE 8.05%
ROCE 5.45%
ROIC 3.91%
ROICexc 4.58%
ROICexgc 6.74%
OM 11.21%
PM (TTM) 6.74%
GM 53.69%
FCFM 13.87%
ROA(3y)-0.73%
ROA(5y)-2.27%
ROE(3y)-1.88%
ROE(5y)-6.88%
ROIC(3y)2.38%
ROIC(5y)N/A
ROICexc(3y)2.73%
ROICexc(5y)N/A
ROICexgc(3y)3.83%
ROICexgc(5y)N/A
ROCE(3y)3.32%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-2.17%
ROICexc growth 3YN/A
ROICexc growth 5Y-3.85%
OM growth 3YN/A
OM growth 5Y-3.91%
PM growth 3YN/A
PM growth 5Y2.11%
GM growth 3Y53.88%
GM growth 5Y0.59%
F-Score5
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF 5.77
Debt/EBITDA 2.79
Cap/Depr 25.67%
Cap/Sales 4.47%
Interest Coverage 250
Cash Conversion 64.06%
Profit Quality 205.7%
Current Ratio 1.96
Quick Ratio 1.69
Altman-Z 1.82
F-Score5
WACC6.74%
ROIC/WACC0.58
Cap/Depr(3y)21%
Cap/Depr(5y)17.01%
Cap/Sales(3y)3.74%
Cap/Sales(5y)3.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.06%
EPS 3YN/A
EPS 5Y-2.17%
EPS Q2Q%58.82%
EPS Next Y30.52%
EPS Next 2Y23.81%
EPS Next 3Y32.98%
EPS Next 5Y27.68%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%7.73%
Revenue Next Year14.07%
Revenue Next 2Y9.93%
Revenue Next 3Y5.73%
Revenue Next 5YN/A
EBIT growth 1Y-32.99%
EBIT growth 3YN/A
EBIT growth 5Y-3.89%
EBIT Next Year168.6%
EBIT Next 3Y50.48%
EBIT Next 5Y35.21%
FCF growth 1Y203.25%
FCF growth 3YN/A
FCF growth 5Y-13.01%
OCF growth 1Y141.86%
OCF growth 3YN/A
OCF growth 5Y-11.83%